Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
33M
-
Shares change
-
+429K
-
Total reported value, excl. options
-
$1.28B
-
Value change
-
+$18.9M
-
Put/Call ratio
-
0.22
-
Number of buys
-
76
-
Number of sells
-
-76
-
Price
-
$38.85
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q2 2021
205 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33M shares
of 51.1M outstanding shares and own 64.55% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.2M shares), VANGUARD GROUP INC (3.94M shares), JPMORGAN CHASE & CO (3.72M shares), STATE STREET CORP (2.26M shares), Redmile Group, LLC (2.14M shares), RTW INVESTMENTS, LP (1.76M shares), DIMENSIONAL FUND ADVISORS LP (952K shares), GEODE CAPITAL MANAGEMENT, LLC (663K shares), Aquilo Capital Management, LLC (595K shares), and UBS Group AG (525K shares).
This table shows the top 168 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.